CN109731136A - 一种软骨诱导性基质材料的制备方法与应用 - Google Patents
一种软骨诱导性基质材料的制备方法与应用 Download PDFInfo
- Publication number
- CN109731136A CN109731136A CN201910027110.XA CN201910027110A CN109731136A CN 109731136 A CN109731136 A CN 109731136A CN 201910027110 A CN201910027110 A CN 201910027110A CN 109731136 A CN109731136 A CN 109731136A
- Authority
- CN
- China
- Prior art keywords
- collagen
- calf
- skin
- host material
- obtains
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000463 material Substances 0.000 title claims abstract description 82
- 210000001612 chondrocyte Anatomy 0.000 title claims abstract description 56
- 230000006698 induction Effects 0.000 title claims abstract description 55
- 238000002360 preparation method Methods 0.000 title claims abstract description 30
- 108010035532 Collagen Proteins 0.000 claims abstract description 110
- 102000008186 Collagen Human genes 0.000 claims abstract description 110
- 229920001436 collagen Polymers 0.000 claims abstract description 107
- 238000005238 degreasing Methods 0.000 claims abstract description 46
- 239000002253 acid Substances 0.000 claims abstract description 22
- 210000001519 tissue Anatomy 0.000 claims abstract description 14
- 238000011049 filling Methods 0.000 claims abstract description 13
- 229910001385 heavy metal Inorganic materials 0.000 claims abstract description 13
- 102000029816 Collagenase Human genes 0.000 claims abstract description 6
- 108060005980 Collagenase Proteins 0.000 claims abstract description 6
- 229960002424 collagenase Drugs 0.000 claims abstract description 6
- 210000003746 feather Anatomy 0.000 claims abstract description 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 48
- 239000000243 solution Substances 0.000 claims description 48
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 44
- 239000006228 supernatant Substances 0.000 claims description 30
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 27
- 230000001954 sterilising effect Effects 0.000 claims description 26
- 239000012043 crude product Substances 0.000 claims description 25
- 238000002347 injection Methods 0.000 claims description 24
- 239000007924 injection Substances 0.000 claims description 24
- 239000011780 sodium chloride Substances 0.000 claims description 22
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 18
- 102000057297 Pepsin A Human genes 0.000 claims description 15
- 108090000284 Pepsin A Proteins 0.000 claims description 15
- 238000005520 cutting process Methods 0.000 claims description 15
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 15
- 229940111202 pepsin Drugs 0.000 claims description 15
- 239000013527 degreasing agent Substances 0.000 claims description 13
- 239000011734 sodium Substances 0.000 claims description 13
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 10
- 239000000654 additive Substances 0.000 claims description 10
- 230000000996 additive effect Effects 0.000 claims description 10
- 238000005119 centrifugation Methods 0.000 claims description 10
- 230000035617 depilation Effects 0.000 claims description 10
- 239000008363 phosphate buffer Substances 0.000 claims description 10
- 230000001376 precipitating effect Effects 0.000 claims description 10
- 239000008213 purified water Substances 0.000 claims description 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 8
- 230000009514 concussion Effects 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 8
- 238000000502 dialysis Methods 0.000 claims description 6
- 229960004756 ethanol Drugs 0.000 claims description 6
- 235000019441 ethanol Nutrition 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 238000007872 degassing Methods 0.000 claims description 5
- 238000001976 enzyme digestion Methods 0.000 claims description 5
- 210000002615 epidermis Anatomy 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 5
- 238000007790 scraping Methods 0.000 claims description 5
- 230000011218 segmentation Effects 0.000 claims description 5
- 238000005406 washing Methods 0.000 claims description 5
- 239000003519 biomedical and dental material Substances 0.000 claims description 4
- 238000007689 inspection Methods 0.000 claims description 4
- 244000309466 calf Species 0.000 claims description 2
- 238000003307 slaughter Methods 0.000 claims description 2
- 150000002978 peroxides Chemical class 0.000 claims 2
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims 1
- 239000000052 vinegar Substances 0.000 claims 1
- 235000021419 vinegar Nutrition 0.000 claims 1
- 210000000845 cartilage Anatomy 0.000 abstract description 16
- 230000007547 defect Effects 0.000 abstract description 9
- 210000000130 stem cell Anatomy 0.000 abstract description 9
- 230000004069 differentiation Effects 0.000 abstract description 6
- 230000008929 regeneration Effects 0.000 abstract description 5
- 238000011069 regeneration method Methods 0.000 abstract description 5
- 210000004872 soft tissue Anatomy 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 3
- 239000012620 biological material Substances 0.000 abstract description 3
- 230000001939 inductive effect Effects 0.000 abstract description 2
- 238000012360 testing method Methods 0.000 description 20
- KFSLWBXXFJQRDL-UHFFFAOYSA-N Peracetic acid Chemical compound CC(=O)OO KFSLWBXXFJQRDL-UHFFFAOYSA-N 0.000 description 16
- 238000004659 sterilization and disinfection Methods 0.000 description 8
- 230000008859 change Effects 0.000 description 6
- 238000002983 circular dichroism Methods 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 4
- 239000000515 collagen sponge Substances 0.000 description 4
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- 239000003292 glue Substances 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 238000010998 test method Methods 0.000 description 3
- 102000012422 Collagen Type I Human genes 0.000 description 2
- 108010022452 Collagen Type I Proteins 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 239000000017 hydrogel Substances 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 210000002901 mesenchymal stem cell Anatomy 0.000 description 2
- 238000004886 process control Methods 0.000 description 2
- 238000012372 quality testing Methods 0.000 description 2
- 238000009777 vacuum freeze-drying Methods 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 206010017076 Fracture Diseases 0.000 description 1
- CTKINSOISVBQLD-UHFFFAOYSA-N Glycidol Chemical compound OCC1CO1 CTKINSOISVBQLD-UHFFFAOYSA-N 0.000 description 1
- 206010021703 Indifference Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000013201 Stress fracture Diseases 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 108010077465 Tropocollagen Proteins 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000004500 asepsis Methods 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000001142 circular dichroism spectrum Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000002138 osteoinductive effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
胶原产率(%) | 无菌检查 | 重金属含量 | |
实施例1 | 82 | 合格 | ≤10μg/g |
实施例2 | 88 | 合格 | ≤10μg/g |
实施例3 | 80 | 合格 | ≤10μg/g |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910027110.XA CN109731136B (zh) | 2019-01-11 | 2019-01-11 | 一种软骨诱导性基质材料的制备方法与应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910027110.XA CN109731136B (zh) | 2019-01-11 | 2019-01-11 | 一种软骨诱导性基质材料的制备方法与应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN109731136A true CN109731136A (zh) | 2019-05-10 |
CN109731136B CN109731136B (zh) | 2020-12-25 |
Family
ID=66364511
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910027110.XA Active CN109731136B (zh) | 2019-01-11 | 2019-01-11 | 一种软骨诱导性基质材料的制备方法与应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN109731136B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110302423A (zh) * | 2019-07-12 | 2019-10-08 | 杭州蓝朗生物技术有限公司 | 一种基于胶原蛋白的软骨再生载体的制备方法 |
CN111346262A (zh) * | 2020-03-17 | 2020-06-30 | 四川大学 | 一种用于促进腱骨愈合的可注射钙磷陶瓷及其制备方法与应用 |
Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001045764A1 (en) * | 1999-12-20 | 2001-06-28 | Verigen Transplantation Service International Ag | Cellular matrix |
US7109300B2 (en) * | 2004-04-19 | 2006-09-19 | Board Of Supervisors Of Louisiana State Univeristy And Agricultural And Mechanical College | Extraction of collagen from calcified tissues |
JP2007124901A (ja) * | 2005-11-01 | 2007-05-24 | Teikyo Univ | コラーゲン抽出方法 |
CN101126104A (zh) * | 2007-05-22 | 2008-02-20 | 上海市食品研究所 | 采用酸酶复合制备天然活性胶原蛋白的方法 |
CN101717804A (zh) * | 2009-12-11 | 2010-06-02 | 四川大学 | 医用级ⅲ型胶原的制备方法 |
CN101810855A (zh) * | 2010-05-20 | 2010-08-25 | 佟刚 | 一种ii型胶原关节软骨修复液及其制备方法 |
CN103785065A (zh) * | 2014-01-24 | 2014-05-14 | 北京大清生物技术有限公司 | 一种软骨再生支架材料的制备方法 |
CN106632666A (zh) * | 2016-12-08 | 2017-05-10 | 广西医科大学 | 一种基于i型胶原质冻胶的软骨诱导方法 |
CN106701879A (zh) * | 2017-03-29 | 2017-05-24 | 武汉医佳宝生物材料有限公司 | 一种提取i型胶原蛋白的方法 |
CN106946988A (zh) * | 2017-04-07 | 2017-07-14 | 李毅 | 一种牛跟腱胶原蛋白的提取方法 |
-
2019
- 2019-01-11 CN CN201910027110.XA patent/CN109731136B/zh active Active
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001045764A1 (en) * | 1999-12-20 | 2001-06-28 | Verigen Transplantation Service International Ag | Cellular matrix |
US7109300B2 (en) * | 2004-04-19 | 2006-09-19 | Board Of Supervisors Of Louisiana State Univeristy And Agricultural And Mechanical College | Extraction of collagen from calcified tissues |
JP2007124901A (ja) * | 2005-11-01 | 2007-05-24 | Teikyo Univ | コラーゲン抽出方法 |
CN101126104A (zh) * | 2007-05-22 | 2008-02-20 | 上海市食品研究所 | 采用酸酶复合制备天然活性胶原蛋白的方法 |
CN101717804A (zh) * | 2009-12-11 | 2010-06-02 | 四川大学 | 医用级ⅲ型胶原的制备方法 |
CN101810855A (zh) * | 2010-05-20 | 2010-08-25 | 佟刚 | 一种ii型胶原关节软骨修复液及其制备方法 |
CN103785065A (zh) * | 2014-01-24 | 2014-05-14 | 北京大清生物技术有限公司 | 一种软骨再生支架材料的制备方法 |
CN106632666A (zh) * | 2016-12-08 | 2017-05-10 | 广西医科大学 | 一种基于i型胶原质冻胶的软骨诱导方法 |
CN106701879A (zh) * | 2017-03-29 | 2017-05-24 | 武汉医佳宝生物材料有限公司 | 一种提取i型胶原蛋白的方法 |
CN106946988A (zh) * | 2017-04-07 | 2017-07-14 | 李毅 | 一种牛跟腱胶原蛋白的提取方法 |
Non-Patent Citations (1)
Title |
---|
林晓艳: "高强度纳米羟基磷灰石/胶原仿骨材料研究", 《中国优秀博硕士学位论文全文数据库(博士) 医药卫生科技辑》 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110302423A (zh) * | 2019-07-12 | 2019-10-08 | 杭州蓝朗生物技术有限公司 | 一种基于胶原蛋白的软骨再生载体的制备方法 |
CN111346262A (zh) * | 2020-03-17 | 2020-06-30 | 四川大学 | 一种用于促进腱骨愈合的可注射钙磷陶瓷及其制备方法与应用 |
CN111346262B (zh) * | 2020-03-17 | 2022-02-01 | 四川大学 | 一种用于促进腱骨愈合的可注射钙磷陶瓷及其制备方法与应用 |
Also Published As
Publication number | Publication date |
---|---|
CN109731136B (zh) | 2020-12-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109568671B (zh) | 一种水凝胶负载细胞的3d骨修复支架及其制备方法 | |
DK173020B1 (da) | Injicerbare materialer fra placenta til forstærkning af blødt væv og fremgangsmåde til fremstilling deraf | |
CN106075598A (zh) | 一种光交联丝胶蛋白水凝胶及其制备方法和应用 | |
CN109054047A (zh) | 一种丝胶/氧化石墨烯复合水凝胶及其制备方法和应用 | |
CN104055795B (zh) | 一种可注射植入剂及其制备方法 | |
CN104307045B (zh) | 一种天然组织来源的脱细胞骨膜材料的制备方法 | |
CN106492285A (zh) | 可注射的脱细胞软骨基质微粒及其在植入剂中的应用 | |
JP2014521415A (ja) | 複合コラーゲンスポンジ及びその製造方法 | |
JP7319915B2 (ja) | 3d印刷可能バイオゲルおよび使用方法 | |
CN112972760B (zh) | 一种负载内皮细胞外基质的3d打印骨缺损修复支架及其制备方法 | |
CN104307044B (zh) | 一种天然组织来源的全椎间盘脱细胞材料的制备方法 | |
CN108992709B (zh) | 一种脱细胞神经基质材料及其制备方法和应用 | |
CN109731136A (zh) | 一种软骨诱导性基质材料的制备方法与应用 | |
CN105802252B (zh) | 一种胶原蛋白改性方法及使用所述方法制得的改性胶原蛋白 | |
US20190015551A1 (en) | Construct for preventing immunological rejection generated when used in transplants, and method for using collagen in a gel state, in the form of dry lyophilised spongy mouldings and 3d matrices | |
CN110585484A (zh) | 一种骨组织用复合骨粉及其制备方法和应用 | |
JP2011510971A (ja) | 中性pHで可溶性の終末的に滅菌されたコラーゲンの製造 | |
CN107890586B (zh) | 一种同种异体生物乳房补片的制备方法 | |
CN114146223A (zh) | 一种重组胶原蛋白复合注射剂及其制备方法 | |
EP2236544A1 (en) | Collagen Implant | |
US20200282107A1 (en) | Sterile clear concentrated solution of biocompatible collagen, process for the preparation and use thereof | |
CN114832156B (zh) | 一种新型医美整形填充物改性左旋聚乳酸凝胶 | |
CN110075356A (zh) | 一种用于外科治疗骨缺损的可塑性填充材料及其制备方法 | |
WO2019168428A1 (ru) | Способ очистки костного и кожного матриксов с использованием сверхкритического флюида | |
KR20060009325A (ko) | 주사가능한 불용성 글로빈 이식체 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
EE01 | Entry into force of recordation of patent licensing contract | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20190510 Assignee: Sichuan baiamong bioactive materials Co.,Ltd. Assignor: SICHUAN University Contract record no.: X2020980006514 Denomination of invention: Preparation and application of a cartilage inducing matrix material License type: Exclusive License Record date: 20200927 |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
EM01 | Change of recordation of patent licensing contract | ||
EM01 | Change of recordation of patent licensing contract |
Change date: 20231123 Contract record no.: X2020980006514 License type after: Common License License type before: Exclusive License |